secwatch.observer — SEC 8-K summary
======================================

Issuer:     PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK:        0001401667
Form:       8-K
Filed at:   2021-07-14T23:59:59+00:00
Accession:  0001193125-21-215227
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Puma Biotechnology appoints Allison Dorval to board of directors
----------------------------------------------------------------

- Appointment effective July 15, 2021; term expires at 2022 annual meeting.
- Dorval also appointed to the Audit Committee.
- Currently CFO of Voyager Therapeutics (since Nov 2018); CPA with life sciences background.
- Will receive standard non-employee director compensation and indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401667/000119312521215227/0001193125-21-215227-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401667/000119312521215227/d119549d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-215227

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer